全文获取类型
收费全文 | 4213733篇 |
免费 | 340959篇 |
国内免费 | 16510篇 |
专业分类
耳鼻咽喉 | 57681篇 |
儿科学 | 135318篇 |
妇产科学 | 112860篇 |
基础医学 | 650242篇 |
口腔科学 | 116300篇 |
临床医学 | 393108篇 |
内科学 | 756572篇 |
皮肤病学 | 104167篇 |
神经病学 | 355589篇 |
特种医学 | 162451篇 |
外国民族医学 | 626篇 |
外科学 | 628450篇 |
综合类 | 123400篇 |
现状与发展 | 24篇 |
一般理论 | 2611篇 |
预防医学 | 365107篇 |
眼科学 | 97255篇 |
药学 | 293360篇 |
31篇 | |
中国医学 | 11716篇 |
肿瘤学 | 204334篇 |
出版年
2021年 | 56041篇 |
2020年 | 35683篇 |
2019年 | 58743篇 |
2018年 | 73971篇 |
2017年 | 56554篇 |
2016年 | 62262篇 |
2015年 | 75663篇 |
2014年 | 110109篇 |
2013年 | 175837篇 |
2012年 | 120596篇 |
2011年 | 125680篇 |
2010年 | 125291篇 |
2009年 | 126685篇 |
2008年 | 110996篇 |
2007年 | 117837篇 |
2006年 | 126042篇 |
2005年 | 121213篇 |
2004年 | 121761篇 |
2003年 | 111441篇 |
2002年 | 100728篇 |
2001年 | 143824篇 |
2000年 | 138554篇 |
1999年 | 129930篇 |
1998年 | 69500篇 |
1997年 | 66286篇 |
1996年 | 64340篇 |
1995年 | 59853篇 |
1994年 | 54110篇 |
1993年 | 50291篇 |
1992年 | 95375篇 |
1991年 | 92367篇 |
1990年 | 88455篇 |
1989年 | 85936篇 |
1988年 | 79832篇 |
1987年 | 78232篇 |
1986年 | 74655篇 |
1985年 | 73262篇 |
1984年 | 62598篇 |
1983年 | 56306篇 |
1982年 | 46779篇 |
1981年 | 43755篇 |
1980年 | 41092篇 |
1979年 | 54735篇 |
1978年 | 45282篇 |
1977年 | 39891篇 |
1976年 | 37423篇 |
1975年 | 36790篇 |
1974年 | 40761篇 |
1973年 | 39642篇 |
1972年 | 37220篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
92.
93.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
94.
95.
96.
97.
98.
Xiying Fan Glen A. Bjerke Kent Riemondy Li Wang Rui Yi 《Molecular carcinogenesis》2019,58(12):2241-2253
MicroRNAs (miRNAs) play important roles in prostate cancer development. However, it remains unclear how individual miRNAs contribute to the initiation and progression of prostate cancer. Here we show that a basal layer‐enriched miRNA is required for prostate tumorigenesis. We identify miR‐205 as the most highly expressed miRNA and enriched in the basal cells of the prostate. Although miR‐205 is not required for normal prostate development and homeostasis, genetic deletion of miR‐205 in a Pten null tumor model significantly compromises tumor progression and does not promote metastasis. In Pten null basal cells, loss of miR‐205 attenuates pAkt levels and promotes cellular senescence. Furthermore, although overexpression of miR‐205 in prostate cancer cells with luminal phenotypes inhibits cell growth in both human and mouse, miR‐205 has a minimal effect on the growth of a normal human prostate cell line. Taken together, we have provided genetic evidence for a requirement of miR‐205 in the progression of Pten null‐induced prostate cancer. 相似文献
99.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
100.
Jeffrey J. Silbiger 《Echocardiography (Mount Kisco, N.Y.)》2019,36(5):954-957
Secondary tricuspid regurgitation (TR) caused by right ventricular enlargement in the setting of left heart disease/pulmonary hypertension has been well described. In contrast, that associated with right atrial enlargement—atrial functional TR (AF‐TR)—remains largely underappreciated. AF‐TR most often occurs in the setting of lone atrial fibrillation, although it is also seen in its absence (idiopathic AF‐TR). Several recent studies have found that the prevalence, hemodynamic significance, and prognosis of AF‐TR are not inconsequential, suggesting increased physician awareness of this novel clinical entity is warranted. This article discusses the pathogenesis, echocardiographic findings, and treatment of this underappreciated cause of secondary TR. 相似文献